Related references
Note: Only part of the references are listed.CEBPA mutations in AML site matters Comment
Lars Bullinger
BLOOD (2022)
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
Satoshi Wakita et al.
BLOOD ADVANCES (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Jialan Niu et al.
FRONTIERS IN ONCOLOGY (2022)
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment
Curtis A. Lachowiez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Current status and future perspectives in targeted therapy of NPM1-mutated AML
Roberta Ranieri et al.
LEUKEMIA (2022)
Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
Tatjana Pandzic et al.
HEMASPHERE (2022)
Male predominance in AML is associated with specific preleukemic mutations
Aviv De-Morgan et al.
LEUKEMIA (2021)
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
Brooks A. Benard et al.
NATURE COMMUNICATIONS (2021)
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
Rosa Ayala et al.
CANCERS (2021)
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia
Noortje van Gils et al.
FRONTIERS IN ONCOLOGY (2021)
Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis
Monica Hellesoy et al.
MOLECULAR ONCOLOGY (2021)
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Claudia Sargas et al.
HAEMATOLOGICA (2021)
Treatment for Relapsed/Refractory Acute Myeloid Leukemia
Felicitas Thol et al.
HEMASPHERE (2021)
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy
Jing Ni et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Advances in targeted therapy for acute myeloid leukemia
Jifeng Yu et al.
BIOMARKER RESEARCH (2020)
Co-Occurring Mutation Clusters Predict Drug Sensitivity in Acute Myeloid Leukemia
Guangrong Qin et al.
BLOOD (2020)
Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
Torsten Haferlach
HEMATOLOGY REPORTS (2020)
Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
Ross L. Levine et al.
HAEMATOLOGICA (2019)
Mechanisms of drug resistance in acute myeloid leukemia
Jing Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Michael Leisch et al.
CANCERS (2019)
Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics
Anna Petrackova et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V. Prassek et al.
HAEMATOLOGICA (2018)
What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies
Yann Guillermin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling
Katherine Tarlock et al.
Oncotarget (2018)
Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
Victoria V. Prassek et al.
HAEMATOLOGICA (2018)
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
Ulrike Bacher et al.
BLOOD CANCER JOURNAL (2018)
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Francesco Mannelli et al.
HAEMATOLOGICA (2017)
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Francesco Mannelli et al.
HAEMATOLOGICA (2017)
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
Lawrence J. Jennings et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors
Rajyalakshmi Luthra et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
David Grimwade et al.
BLOOD (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutations in AML: prognostic and therapeutic implications
Courtney D. DiNardo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Current practices and guidelines for clinical next-generation sequencing oncology testing
Samuel P. Strom et al.
Cancer Biology & Medicine (2016)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)